Details for Patent: 8,648,077
Which drugs does patent 8,648,077 protect, and when does it expire?
Patent 8,648,077 protects CAPLYTA and is included in one NDA.
This patent has twenty-two patent family members in sixteen countries.
Summary for Patent: 8,648,077
| Title: | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals |
| Abstract: | The present invention relates to toluenesulfonic acid addition salt crystals of 4-((6bR,10aS)-3-Methyl-2,3,6b,9,10,10a-Hexahydro-1H-Pyrido[3′,4′:4,5]Pyrrolo[1,2,3-De]Quinoxalin-8(7H)-yl)-1-(4-Fluorophenyl)-1-Butanone, the method of making and using such crystals. |
| Inventor(s): | John Tomesch, Lawrence P. Wennogle |
| Assignee: | Intra Cellular Therapies Inc |
| Application Number: | US12/922,056 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,648,077 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 8,648,077
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intra-cellular | CAPLYTA | lumateperone tosylate | CAPSULE;ORAL | 209500-002 | Apr 22, 2022 | RX | Yes | No | 8,648,077 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Intra-cellular | CAPLYTA | lumateperone tosylate | CAPSULE;ORAL | 209500-003 | Apr 22, 2022 | RX | Yes | No | 8,648,077 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Intra-cellular | CAPLYTA | lumateperone tosylate | CAPSULE;ORAL | 209500-001 | Dec 20, 2019 | RX | Yes | Yes | 8,648,077 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,648,077
| PCT Information | |||
| PCT Filed | March 12, 2009 | PCT Application Number: | PCT/US2009/001608 |
| PCT Publication Date: | September 17, 2009 | PCT Publication Number: | WO2009/114181 |
International Family Members for US Patent 8,648,077
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009223701 | ⤷ Start Trial | |||
| Canada | 2716730 | ⤷ Start Trial | |||
| China | 102046175 | ⤷ Start Trial | |||
| China | 105237536 | ⤷ Start Trial | |||
| Denmark | 2262505 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
